Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

DexCom Inc (DXCM)

  • Business News
  • Dec. 04, 2025, 13:02 UTC
  • 9
  • 1 comments

Listening to Healthcare Professionals: Dexcom Launches New Education Offering, Dexcom Academy

Market reaction Comment Full text

Aclarion Inc (ACON)

  • Business News
  • Dec. 04, 2025, 13:00 UTC
  • 9
  • 1 comments

Aclarion Announces Publication of Nociscan Article in Special Pain Issue of the International Journal of Spine Surgery (IJSS)

Market reaction Comment Full text

Enlivex Therapeutics Ltd. (ENLV)

  • Business News
  • Dec. 04, 2025, 13:00 UTC
  • 9
  • 1 comments

Enlivex Management to Host Fireside Chat on December 11 to Discuss RAIN Token Strategy and Allocetra Clinical Development

Market reaction Comment Full text

Precipio Inc (PRPO)

  • Business News
  • Dec. 04, 2025, 13:00 UTC
  • 9
  • 1 comments

Precipio Identifies Unauthorized Access to Isolated Storage; No Operational Impact

Market reaction Comment Full text

Estrella Immunopharma Inc. (ESLA)

  • Business News
  • Dec. 04, 2025, 13:00 UTC
  • 10
  • 1 comments

Estrella Advances STARLIGHT-1 Trial into Phase II Following Positive DSMB Recommendation

Market reaction Comment Full text

ENDRA Life Sciences Inc (NDRA)

  • Business News
  • Dec. 04, 2025, 13:00 UTC
  • 9
  • 1 comments

ENDRA’s TAEUS® Liver Matches MRI-PDFF Performance at Key Clinical Thresholds, Positioning Device for MASLD/MASH Trial Use

Market reaction Comment Full text

MoonLake Immunotherapeutics (MLTX)

  • Business News
  • Dec. 04, 2025, 12:52 UTC
  • 7
  • 1 comments

MoonLake Immunotherapeutics Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - MLTX

Market reaction Comment Full text

Baxter International Inc (BAX)

  • Business News
  • Dec. 04, 2025, 12:51 UTC
  • 7
  • 1 comments

Baxter - Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Market reaction Comment Full text

Baxter International Inc (BAX)

  • Business News
  • Dec. 04, 2025, 12:51 UTC
  • 11
  • 1 comments

Baxter Announces Early Tender Results for 2.600% Senior Notes Due 2026 and 1.915% Senior Notes Due 2027

Market reaction Comment Full text

MoonLake Immunotherapeutics (MLTX)

  • Business News
  • Dec. 04, 2025, 12:51 UTC
  • 17
  • 1 comments

MLTX Investors Have Opportunity to Lead MoonLake Immunotherapeutics Securities Fraud Lawsuit with the Schall Law Firm

Market reaction Comment Full text
  • Previous
  • 424
  • 425
  • 426
  • 427
  • 428
  • Next

Search

News categories

  • Technical Exchange News(10921)
  • Event(2340)
  • SEC News(190955)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125006)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin